Compare CTRI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTRI | VCEL |
|---|---|---|
| Founded | 1909 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2024 | 1996 |
| Metric | CTRI | VCEL |
|---|---|---|
| Price | $27.59 | $44.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $29.88 | ★ $57.75 |
| AVG Volume (30 Days) | ★ 1.6M | 604.6K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 412.50 | 60.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,982,781,000.00 | $276,259,000.00 |
| Revenue This Year | $14.62 | $19.40 |
| Revenue Next Year | $8.16 | $18.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 13.10 | ★ 16.45 |
| 52 Week Low | $19.04 | $28.95 |
| 52 Week High | $42.99 | $48.75 |
| Indicator | CTRI | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 52.92 |
| Support Level | $25.05 | $44.56 |
| Resistance Level | $32.52 | $48.75 |
| Average True Range (ATR) | 0.95 | 1.66 |
| MACD | 0.23 | -0.63 |
| Stochastic Oscillator | 87.95 | 18.65 |
Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.